Publication of NI Cancer Waiting Times Statistics Release (January – March 2022)

Date published: 30 June 2022

The Department of Health today published the NI Cancer Waiting Times Statistics Release for January, February and March 2022.

doh latest statistics

The release gives details of the waiting times for patients accessing cancer services at hospitals during January, February and March 2022.

Key facts and figures are listed below:

Waiting times for first treatment following an urgent GP referral for suspect cancer (62 day target)

  • In March 2022, 414 patients commenced their first treatment for cancer following an urgent referral for suspect cancer. Of these, 48.1% (199 patients) started treatment within 62 days, compared with 41.2% (175 of the 425 patients) in February, 33.8% (142 of the 420 patients) in January and 49.2% (216 of the 439 patients) in March 2021.

Waiting times for first definitive treatment following a decision to treat (31 day target)

  • During March 2022, 872 patients commenced their first treatment for cancer following a decision to treat being taken. Of these, 88.5% (772) started treatment within 31 days, compared with 88.2% (769 of the 872 patients) in February, 82.1% (734 of the 894 patients) in January and 86.6% (767 of the 886 patients) in March 2021.

Patients first seen following an urgent referral for suspect breast cancer (14 day target)

  • During March 2022, 1,376 patients were seen by a breast cancer specialist for a first assessment following an urgent referral for suspect breast cancer. Of these, 43.6% (600) were seen within 14 days, compared with 54.3% (666 of the 1,226 patients) in February, 55.1% (692 of the 1,255 patients) in January and 33.2% (508 of the 1,530 patients) in March 2021.

Referrals for suspect breast cancer

  • In March 2022, 2,189 new referrals for suspect breast cancer were received; this compares to 2,010 in February, 2,305 in January and 2,380 in March 2021. Referrals for suspect breast cancer can be for advice, assessment or both.
  • Of those new referrals for suspect breast cancer in March 2022, 1,446 (66.1%) were classified as urgent.

Notes to editors: 

  1. All  statistical publications relating to cancer waiting times are available online the DoH website.

2.  About the data

  • The sources for the data contained in this release are the Cancer Patient Pathway System (CaPPS) and the Patient Administration System (PAS).
  • Figures also include all patients living outside Northern Ireland and privately funded patients seen or treated in Health and Social Care hospitals in Northern Ireland.
  • Data include all returns and amendments received from HSC Trusts up to 27 June 2022.
  1. Ministerial Target for Cancer Waiting Times

The draft 2021/22 Ministerial target has three components associated with cancer waiting times:

  • The Ministerial Target on waiting times for treatment following an urgent referral for suspect cancer states that, ‘During 2021/22, 95% of patients urgently referred with a suspect cancer should begin their treatment within 62 days’.
  • The Ministerial Target on waiting times for cancer treatment following a decision to treat states that, ‘During 2021/22, at least 98% of patients diagnosed with cancer should receive their first definitive treatment within 31 days of a decision to treat’.
  • The Ministerial Target on waiting times for a first assessment with a breast cancer specialist states that, ‘During 2021/22, all urgent breast cancer referrals should be seen within 14 days’.
  1. Definition of Waiting Times for Treatment following an urgent referral for Suspect Cancer
  • These data relate to patients who received a first definitive treatment for cancer (having been given an ‘International Classification of Diseases 10’ (ICD 10) diagnosis) during each of the three months covered in the publication, following an urgent referral for suspect cancer from a General Practitioner or a routine GP referral that has subsequently been reclassified as urgent by a cancer specialist.  Data for all cancers are included with the exception of basal cell carcinoma.  Referrals from sources other than a GP, routine referrals and patients who have not been given an ICD 10 diagnosis are excluded.
  • The completed waiting time is measured from the date an initial urgent GP referral for suspect cancer is received by the Provider HSC Trust and ends on the date the patient receives their first treatment for cancer. Adjustments are made to the completed waiting time in the event of a patient cancelling or self-deferring treatment or as a result of suspension for either medical or social reasons.
  1. Definition of Waiting Times for Treatment following a Decision to Treat for   cancer
  • These data relate to all patients who received a first definitive treatment for cancer (having been given an ICD 10 diagnosis) during each of the three months covered in the publication, irrespective of their source or type of referral.  Data include treatment for all cancers, with the exception of basal cell carcinoma.  Patients that have not been given an ICD 10 diagnosis are excluded.
  • The completed waiting time is measured from the date a decision is taken to treat a patient for cancer and ends on the date that the patient receives their first definitive treatment for cancer. The decision to treat is the date on which the patient and the clinician agree the planned treatment. Adjustments are made to the completed waiting time in the event of a patient cancelling or self deferring treatment or as a result of suspension for either medical or social reasons.
  1. Definition of Waiting Times for a First Assessment with a Breast Cancer Specialist
  • These data relate to urgent referrals (excluding those that have been reclassified as routine by the breast cancer specialist) and include routine referrals that have subsequently been reclassified as urgent by a breast cancer specialist.
  • The completed waiting time is measured from the date an initial breast cancer referral is first received by the Provider HSC Trust, and ends on the date that the patient attends their first outpatient appointment with a breast cancer specialist. Adjustments are made to the completed waiting time in the event of a patient cancelling, self-deferring or failing to attend a first outpatient appointment.
  1. Number of referrals for suspect breast cancer
  • Data relate solely to patients who were referred with suspect breast cancer during each month. All sources of referral irrespective of their source of referral are included i.e. urgent and routine referrals from both General Practitioners and other medical professionals. Referrals for suspect breast cancer can be for advice, assessment or both.
  • Information on new suspect breast cancer referrals provided by HSC Trusts is not National Statistics but has been validated and quality assured by HSC Trusts prior to publication. Currently the Department is in the process of refining validation processes for these data, which should therefore be treated with caution. However, they have been published to help provide users with some contextual information in relation to the Ministerial Target relating to breast cancer waiting times.
  1. This information was collated by Hospital Information Branch, DoH.

9. Further information is available from:
Hospital Information Branch
Department of Health
Annex 2, Castle Buildings
Stormont, BT4 3SQ

Telephone: 028 90 765725
E-mail: Statistics@health-ni.gov.uk
Internet: https://www.health-ni.gov.uk/topics/doh-statistics-and-research
 

  1. For media enquiries please contact DoH Press Office by email: pressoffice@health-ni.gov.uk. 
  2. Follow us on twitter @healthdpt.
  3. The Executive Information Service operates an out of hours service For Media Enquiries Only between 1800hrs and 0800hrs Monday to Friday and at weekends and public holidays. The duty press officer can be contacted on 028 9037 8110.

 

Share this page

Back to top